
June 21 (Reuters) - MetaVia Inc MTVA.O:
METAVIA PRESENTS PRE-CLINICAL DATA ON DA-1241 DEMONSTRATING ADDITIVE HEPATOPROTECTIVE EFFECTS IN COMBINATION WITH EFRUXIFERMIN AT THE ADA'S 85TH SCIENTIFIC SESSION
METAVIA INC - COMBINATION THERAPY DECREASES INFLAMMATORY AND FIBROTIC GENE EXPRESSION
METAVIA INC - COMBINATION THERAPY REDUCES INFLAMMATORY AND FIBROTIC PROTEINS IN THE LIVER